Clinical Trials - June 25, 2015
Psoriasis Foam Shows Promise
New data from LEO Pharma A/S shows aerosol foam Enstilar, the company’s dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch relief and improvements in itch-related sleep loss for patients suffering from psoriasis. The data is from a PSO-FAST Phase 3 clinical trial. Between 70 percent and 90 percent of people […]